Percutaneous transhepatic stenting by Wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation.
Posttransplant lymphoproliferative disorders are infrequent tumors related to chronic immunosuppressive therapy. We present a liver transplant recipient who developed such a tumor in the porta hepatis that provoked obstruction of the entire portal triad. Treatment consisted of systemic chemotherapy, percutaneous dilatation, and placement of Wallstent endoprostheses across both biliary and portal vein stenoses. The patient died 3 weeks later of pneumonia and sepsis. At necropsy, the tumor was completely necrosed and the prostheses in both the common bile duct and the portal vein were patent.
Bilbao
J I
JI
Department of Radiology, Clinica Universitaria de Navarra, Pamplona, Spain.
Ruza
M
M
Longo
J M
JM
Mansilla
F
F
Picardi
A
A
de Villa
V
V
Pardo
F
F
Sola
J
J
Quiroga
J
J
D002779:Cholestasis / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D003251:Constriction, Pathologic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000209:etiology; D016031:Liver Transplantation / Q000009:adverse effects*; D016400:Lymphoma, Large-Cell, Immunoblastic / Q000150:complications* / Q000209:etiology; D008875:Middle Aged; D011169:Portal Vein / Q000000981:diagnostic imaging / Q000473:pathology*; D011677:Punctures; D015641:Radiography, Interventional; D015607:Stents